dcorrigan

Publications of the Week

As one of the leading causes of global mortality, cancer has prompted extensive research and…

dcorriganSeptember 21, 2022

Local News

A cutting-edge procedure for epilepsy at Seattle Children’s, known as responsive neurostimulation (RNS), is offering…

dcorriganSeptember 20, 2022

Local News

Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of…

dcorriganSeptember 20, 2022

Local News

Omeros Corporation reported results from the narsoplimab arm of the I-SPY COVID Trial, sponsored by…

dcorriganSeptember 19, 2022

Local News

Over the past two years, machine learning has revolutionized protein structure prediction. Now, three papers…

dcorriganSeptember 19, 2022

Publications of the Week

PIK3CA-related overgrowth spectrum (PROS) conditions of the head and neck are treatment challenges. Traditionally, these…

dcorriganSeptember 19, 2022

Local News

Washington Research Foundation (WRF), a leader in advancing life sciences in Washington state, announces Tom…

dcorriganSeptember 16, 2022

Local News

Calling “Emerald City” his home, it is common to find Seattle-based x-ray crystallographer and coffee…

dcorriganSeptember 16, 2022

Local News

The UW Molecular Engineering & Sciences Institute welcomed thir 9th cohort of future molecular engineers,…

dcorriganSeptember 15, 2022

Publications of the Week

Preferentially Expressed Antigen in Melanoma (PRAME) , a cancer testes antigen provides an ideal target…

dcorriganSeptember 15, 2022